For the first time, researchers have determined virtually the entire genome of a fetus using only a blood sample from the pregnant woman and a saliva specimen from the father.The accomplishment heralds an era in which parents might find it easier to know the complete DNA blueprint of a child months

The Health Intervention and Technology Assessment Program (HITAP) was established in 2007 as a non-profit organization. Its main responsibility is to assess health interventions and technology assessment with the coverage of pharmaceuticals, medical devices, interventions, individual and community health promotions and disease prevention, as well a

This study is the first stage under the project of development and evaluation concerning the effectiveness of measures to prevent self-harm in Thailand. The problem conditions, involved factors, signals prior to self-harm and measures to prevent self-harm in selected province were studied. The study results illustrate the problems of inaccessibili

The abundance of various innovations in healthcare (pharmaceuticals, medical devices, interventions, individual and community health promotion and disease prevention as well as a social health policy) have been continuously used in the healthcare system, resulting in a higher demand for resources and budgets in disease prevention and healthcare. Th

Kenya’s President, His Excellency Uhuru Kenyatta has committed his government to attaining the “Big Four” agenda on 1) Food security, 2) Affordable housing, 3) Manufacturing, and 4) affordable healthcare for all by 2022. This agenda is linked to Kenya’s Vision 2030 which sought to achieve Universal

India has established Health Technology Assessment (HTA) to increase the use of evidence in informing health policy decisions. The Post-Graduate Institute of Medical Education and Research (PGIMER), a resource hub for HTA and a leading public health institution in India, hosted a workshop titled “Co

Criteria for priority setting of HIV/AIDS interventions in Thailand: a discrete choice experiment Sitaporn Youngkong*1,2, Rob Baltussen*1, Sripen Tantivess*2, Xander Koolman*3 and Yot Teerawattananon*2 1 Nijmegen International Center for Health Systems Research and Education (NICHE), Department of

Sripen Tantivess & Viroj Tangcharoensathien Abstract Thailand achieves universal health coverage through the introduction of 3 benefit schemes: the Civil Servant Medical Benefit Scheme (CSMBS), Social Security Scheme, and Universal Coverage Scheme. The primary benefit package of these sche

Development cannot be contained in a numerical measure of Gross National Product/Gross Domestic Product (GNP/GDP), conceding this the UN gave a universal call to its member nations for the Sustainable Development Goals (SDGs). The SDG 3 explicitly states “ensuring healthy lives and promote well-bein

ABSTRACT Objectives: This study aimed to analyse the cost–utility and budget impact of adding tocilizumab to the standard treatment for patients with refractory systemic juvenile idiopathic arthritis (sJIA) in Thailand. Design: Economic evaluation using a decision-analytical model. Setting: